MYOM2 and Miyoshi myopathy: Trajectory definitions were proposed for hemoglobin (increasing anemia) in the initial PANGEA model28, followed by evolving M-protein and/or total immunoglobulin increase, and evolving sFLC, and were associated in multiple studies with a significantly shorter time-to-progression to MM.